Mute
Mateus Vandesteen
Bedinvetmab X Neuroplasticidade Estudos recentes têm levantado preocupações sobre o Bedinvetmab (nome comercial: Librela), um anticorpo monoclonal amplamente utilizado no controle da dor articular crônica em cães idosos. Ele atua inibindo o Fator de Crescimento Nervoso (NGF), um elemento fundamental para a modulação da dor, mas também essencial na manutenção e regeneração de neurônios sensoriais e centrais. Essa inibição prolongada pode afetar áreas cerebrais envolvidas na cognição e memória. (
Follow
36
1
7
kwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwaikwai kwaikwaikwaikwaikwaikwaikwaikwaikwaikwai